PATHOLOGY REVISION NOTES BASED ON HIGH YIELD TOPICS
AND LECTURE NOTES
LEUKEMIA AND LYMPHOMA
HIGH YIELD TOPICS
MEDICINE HEMATOLOGY BASICS
IMAGE BASED QUESTIONS
PERIPHERAL SMEAR
This presentation describes the technique of bone marrow aspiration and biopsy and shows the maturation of elements in sequence and finally adds a note on how to report a bone marrow slide
This presentation describes the technique of bone marrow aspiration and biopsy and shows the maturation of elements in sequence and finally adds a note on how to report a bone marrow slide
Lab Diagnosis of Chronic lymphoproliferative disorders (CLPD);Flowcytometric...Dr Siddartha
Lab Diagnosis of Chronic lymphoproliferative disorders (CLPD);Flowcytometric Evaluation
Basavatarakam Indo-American Cancer Hospital and Research Institute
An array of presentation of lymphoma spillover in the peripheral smear and bone marrow. All types of lymphomas are discussed along with a bouquet of HPE pictures
technique of preparing imprint smear# comparision with frozen sections# application and its role in thyroid ,paathyroid,breast,skin,head and neck and mucinous tumors# advantages and limitations
Lab Diagnosis of Chronic lymphoproliferative disorders (CLPD);Flowcytometric...Dr Siddartha
Lab Diagnosis of Chronic lymphoproliferative disorders (CLPD);Flowcytometric Evaluation
Basavatarakam Indo-American Cancer Hospital and Research Institute
An array of presentation of lymphoma spillover in the peripheral smear and bone marrow. All types of lymphomas are discussed along with a bouquet of HPE pictures
technique of preparing imprint smear# comparision with frozen sections# application and its role in thyroid ,paathyroid,breast,skin,head and neck and mucinous tumors# advantages and limitations
hematology revision notes for neet pg aiims pg preparation based on lecture notes
high yield point based on previous year questions
image based questions for neet pg aiims preparation
arthritis
c anca
p anca
SLE
manifestation
treatment
juvenile dermatomyositis
v sign
shawl sign
arthritis
psoriatic arthritis
rheumatoid
rheumatic
arthritis type
synovial fluid
cells
symptoms pathology
treatment
synoc
derna
Approach to Pancytopenia with cases.pptxYogeetaTanty1
Approach to pancytopenia with case based discussion and brief details regarding each condition. Causes of pancytopenia. Details of congenital causes of aplastic anemia.
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...VarunMahajani
Disruption of blood supply to lung alveoli due to blockage of one or more pulmonary blood vessels is called as Pulmonary thromboembolism. In this presentation we will discuss its causes, types and its management in depth.
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
The prostate is an exocrine gland of the male mammalian reproductive system
It is a walnut-sized gland that forms part of the male reproductive system and is located in front of the rectum and just below the urinary bladder
Function is to store and secrete a clear, slightly alkaline fluid that constitutes 10-30% of the volume of the seminal fluid that along with the spermatozoa, constitutes semen
A healthy human prostate measures (4cm-vertical, by 3cm-horizontal, 2cm ant-post ).
It surrounds the urethra just below the urinary bladder. It has anterior, median, posterior and two lateral lobes
It’s work is regulated by androgens which are responsible for male sex characteristics
Generalised disease of the prostate due to hormonal derangement which leads to non malignant enlargement of the gland (increase in the number of epithelial cells and stromal tissue)to cause compression of the urethra leading to symptoms (LUTS
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
3. 22-04-2018
• Immature forms present
• Early mature neutrophils are seen in leukemoid reaction
• Immature forms typically seen in CML
• LAP score is elevated in leukemoid reaction
• Depressed in CML
• No orgnaomegaly
• Organomegaly + in CML
• Basophilia eosinophilia thrombocytosis
• In CML
• Absent in leukemoid reactionsTONY SCARIA
2010 KMC
TONY SCARIA
2010 KMC
8. 22-04-2018
In ALL
• Cytochemical stain PAS +ve
• Dot like
• Block like
TONY SCARIA
2010 KMC
PAS positivity is due to glycogen deposits in
lymphoblast
TONY SCARIA
2010 KMC
9. 22-04-2018
In M6 of AML
• Diffuse positivity by PAS
TONY SCARIA
2010 KMC
TONY SCARIA
2010 KMC
11. 22-04-2018
MPO positivity for granules in myelocytes
TONY SCARIA
2010 KMC
Non specific esterase staining for M3 M4 M5
The blasts show a strong positive reaction for non-specific
esterase, as observed by the dense orange cytoplasmic
staining. This reaction is positive in monocytic cells, and
negative in granulocytes.
TONY SCARIA
2010 KMC
14. 22-04-2018
TONY SCARIA
2010 KMC
• Tdt(terminal deoxytransferase ) a DNA polymerase present in Pre B
ALL & Pre T ALL
TONY SCARIA
2010 KMC
15. 22-04-2018
Cytogenetics in Pre B ALL
• B cell ALL is associated with
• loss of function mutation in PAX5, E2A and EBF or
• balanced t (12;21) affecting ETV6 and RUNX1 genes (normally required for B
cell development).
• Hyperdiploidy MC cytogenetic change
• Trisomy 4 7 & 10
• Hypoploidy
• Both hypoploidy & hyperploidy are pesent in pre B ALL
TONY SCARIA
2010 KMC
Loss of function mutation of E2A EBF PAX5
TONY SCARIA
2010 KMC
17. 22-04-2018
CD10 common ALL antigen
Pre B ALL express TdT CD 10 CD 19 CD20 PAX5
TONY SCARIA
2010 KMC
Pre T ALL
• 15 % cases
• Teenage (13 – 17 yrs of age ) in boys
• Presents as a mediastinal mass in thymus
• Early testicular involvement & early CNS manifestation d/t meningeal
spread
TONY SCARIA
2010 KMC
18. 22-04-2018
Molecular patho genesis in Pre T ALL
• Gain of function mutation in NOTCH 1
TONY SCARIA
2010 KMC
Pre T ALL
• Teenagers
• Thymic involvement
• Testicular involvement poor prognosis
TONY SCARIA
2010 KMC
19. 22-04-2018
Immunophenotype in pre T ALL
• TdT
• CD1
• CD2
• CD5
• CD7
TONY SCARIA
2010 KMC
Good prognosis
• Age 2-10 years
• Female sex
• white race
• Peripheral blast count <10,000
• Pre B-cell phenotype(CALLA +ve)
• L1 morphology
• Absence of mediastinal mass
• Absence of CNS involvement
• Absence of testicular involvement
• Hyperdiploidy (>50 chromosomes)
• t(12;21) or t (9:12)
• Trisomy 4,7 and 10
Bad prognosis
• Age <1 year or > 10 years
• Male sex
• Black
• Peripheral blast count >50,000
• Pre T-cell phenotype
• L2 L3 morphology
• Mediastinal mass
• CNS involvement
• Testicular involvement
• Pseudodiploidy or
• t (9;22) (Philadelphia chromosome) or t (8;14) or t
(4;11)
TONY SCARIA
2010 KMC
26. 22-04-2018
AML with recurrent genetic abnormalities
• AML t(8:21) RUNx1 fusion gene (M2)
• AML inv (16) M4E0
• Acute promyelocytic leukemia t (15:17) M3
• AML t 11q 23 MLL fusion gene bad prognosis
• AML with normal cytogenetics & mutated NPM (nucleophosmin)
TONY SCARIA
2010 KMC
AML therapy related
• Alkylating therapy MDS like cytogenetics changes (5q-7q-)latency
of 2-8 years
• Following of topoisomerase II inhibitors 1-3 yrs of latency
TONY SCARIA
2010 KMC
27. 22-04-2018
AML with MDS like features
• Dysplastic changes & cytogenetics of 5q 7q 20 q
TONY SCARIA
2010 KMC
TONY SCARIA
2010 KMC
29. 22-04-2018
AML M3 t(15:17)
• Multiple auer rods (Faggot cells)
• Heavily granulated strong
MPO+positivity
• Granules contain procoagulant
DIC
• Common in young female DIC
manifest as menorrhagia
TONY SCARIA
2010 KMC
AML M3
TONY SCARIA
2010 KMC
30. 22-04-2018
AML M5 gingival hyperplasia
TONY SCARIA
2010 KMC
pancytopenia
TONY SCARIA
2010 KMC
31. 22-04-2018
Criteria for remission in AML
• Platelet count > 1lakh
• Neutrophil >1500
• Bone marrow blast <5 % and absent auer rods
• Absence of extra medullary lesion
TONY SCARIA
2010 KMC
Chloroma
TONY SCARIA
2010 KMC
32. 22-04-2018
Chloroma / myeloid sarcoma /granulocytic
sarcoma
• Solid tumour with myeloblast
• Extramedullary manifestation of AML
• May be hidden manifestation of AML (common in M2 / monocytic (M3orM4)
• Follow up for development of AML with bone marrow transplantation
• Mc seen in skin of orbit & periorbital tissue
TONY SCARIA
2010 KMC
TONY SCARIA
2010 KMC
33. 22-04-2018
Arbinskov cells are monocytes in chloroma
TONY SCARIA
2010 KMC
Markers for granulocytic sarcoma
• CD 33
• CD 43
• CD 117
• Myeloperoxidase
• Lysozyme
TONY SCARIA
2010 KMC
34. 22-04-2018
CLL
TONY SCARIA
2010 KMC
CLL
• Absolute lymphocyte count > 5000 cell/mm3
• Males are more commonly affected
• > 60 yrs
• Most common lymphoma in western world
TONY SCARIA
2010 KMC
35. 22-04-2018
CF
Symptoms
• Fatigue (commonest
presentation)
• Infections d/t
hypogammaglobulinemia
Signs
• Lymphadenopathy
• Initially cervical generalised
• Hepatosplenomegaly
•
TONY SCARIA
2010 KMC
• Both cell types are affected
• B cell types & T cell types (B cell >> t cell)
• Hypogammaglobulinemia +
• Auto Ab against RBC AIHA
TONY SCARIA
2010 KMC
36. 22-04-2018
• diagnostic criteria for CLL are:
• • Peripheral blood lymphocyte count >5000 cells/mm3with <55% cells being
atypical.
• • Bone marrow aspirate showing >30 % lymphocytes
TONY SCARIA
2010 KMC
• deletion of 13q
• commonest and has good prognosis
• Tumour suppressor genes miR15 a & miR16-
1+ on chr 13
• Deletion 11q
• trisomy 12q and
• deletion of 17p
have poor prognosis
TONY SCARIA
2010 KMC
37. 22-04-2018
• IOC
• Flowcytometry
• Used to detect lymphocytosis & immunophenotyping
• Immunophenotyping} CD 5 CD23 CD19 cD20
TONY SCARIA
2010 KMC
Peripheral smear
• Smudge cells /parachute cells/basket
cells
• Slide artefact
• Tumour cells appear as fragile disrupted
tumour cells
formation
• Due to lack of vimentin (cytoskeletal protein
required for rigidity & integrity of cells
Smudge cells are also seen
in infections CLL a/c
leukemia
TONY SCARIA
2010 KMC
38. 22-04-2018
Lymph node biopsy
• Large mitotic cells known as
prolymphocytes
• Divide & form diagnostic
proliferation centres
• Distortion of architecture
• Diffue effacement of LN
architecture
• Commonest
• d/t proliferation cenrtres
• Pseudofollicular pattern
• Rare TONY SCARIA
2010 KMC
Diffuse effacement of LN
TONY SCARIA
2010 KMC
39. 22-04-2018
Basket cells in CLL
TONY SCARIA
2010 KMC
Bad prognosis
• Expression of ZAP 70
• Presence of NOTCH 1 mutation
• Deletions of 11q 17 p or trisomy 12
TONY SCARIA
2010 KMC
40. 22-04-2018
ZAP 70 a/w poor prognosis
TONY SCARIA
2010 KMC
ZAP 70 is a/w drug resistance
TONY SCARIA
2010 KMC
41. 22-04-2018
TONY SCARIA
2010 KMC
Transformations in CLL
• Prolymphocytic transformation
• Cb worsening of cytopenia increasing splenomegaly & large number of
prolymphocytes in circulation
• Richter syndrome
TONY SCARIA
2010 KMC
42. 22-04-2018
Richter syndrome
• Transformation of CLL in
to DLBL
• Presents as rapidly
enlarging mass in spleen
or LN
TONY SCARIA
2010 KMC
Myelodysplastic syndrome
TONY SCARIA
2010 KMC
43. 22-04-2018
Myelodysplastic syndrome
• Clonal stem cell disorder
• Ineffective haematopoesis
• Transformation to AML
• DD of megaloblastic anemia
TONY SCARIA
2010 KMC
• 1. Primary MDS – Develops slowly usually after 50 years of age.
• 2. Secondary or Therapy related MDS (t-MDS) –
• Usually 2 to 8 years after toxic drug or radiation exposure. The secondary
MDS gets transformed to AML most frequently and so has a poorer prognosis.
TONY SCARIA
2010 KMC
45. 22-04-2018
Erythroid lineage shows ringed sideroblast
• Iron laden
mitochondria in
perinuclear area
• Visible as blue
granules in Prussian
blue staining
• Also ssen in
• MDS
• Pb poisoning
• Sideroblastic
anemia
TONY SCARIA
2010 KMC
TONY SCARIA
2010 KMC
46. 22-04-2018
MDS is cb DOHLE bodies in granulocytic
lineage
• Damaged RER
• Also seen in MDS
• Sepsis
• Chediak higashi syndrome
TONY SCARIA
2010 KMC
Granulocytic lineage also has pseudo pelger
huet anomaly
• Neutrophil with bilobed nuclei
• MDS
• AML with dysplastic maturation
• CML during accelerated phase
TONY SCARIA
2010 KMC
47. 22-04-2018
Megakaryocyte lineage pawn ball
appearance
• Either a single nuclear lobe or
multiple separate nuclei
TONY SCARIA
2010 KMC
TONY SCARIA
2010 KMC
48. 22-04-2018
TONY SCARIA
2010 KMC
Rx
• erythropoetin
• G CSF
• Lenalidomide
• Azacytidine
• antimetabolite that inhibits DNA methylation
• BM transplantation
TONY SCARIA
2010 KMC
49. 22-04-2018
Myeloproliferative disorders
• CML
• Polycythemia vera
• Essential thrombocythemia
• c/c idiopathic myelofibrosis
• c./c neutrophilic leukemia
• c/c eosinophilous leukemia
TONY SCARIA
2010 KMC
Common feature of MPD
• Increased proliferative drive in the marrow
• Extra medullary haematopoesis
• Spent phase transformation
• Cb marrow fibrosis & peripheral blood cytopenia
• a./c leukemia transformation
TONY SCARIA
2010 KMC
50. 22-04-2018
• MPD may undergo transformation in to a/c leukemia
• Diagnosed by BM examination
• Blood count
• To determine proliferating cell line
• Marrow infiltration decrease in normal cells
TONY SCARIA
2010 KMC
CML
TONY SCARIA
2010 KMC
51. 22-04-2018
Philadelphia chromosome / reciprocal
translocation / Chr t (9:22)
TONY SCARIA
2010 KMC
• LAP score will be elevated in accelerate & blast crisis
• But decreased in chronic phase
TONY SCARIA
2010 KMC
52. 22-04-2018
P/S in CML
• Leucocytosis (>1,00,000)
• Blast count <10 %
• Consist of neutrophils (band
forms metamyelocytes &
myocytes) eosinophils &
basophils
TONY SCARIA
2010 KMC
TONY SCARIA
2010 KMC
55. 22-04-2018
TONY SCARIA
2010 KMC
Prognostic markers
• Soklal index
• Age
• Blast (circulating)
• Cytogenetic changes
• Platelet count
• Spleen size
• Hasford index
• Age
• Blast (circulating )
• Basophils & eosinophils
• Platelet count
• Spleen size TONY SCARIA
2010 KMC
56. 22-04-2018
TONY SCARIA
2010 KMC
Rx
• Allogenic or syngenic bone marrow transplant
• Patients in early chronic phase
• Imatinib (also used in treatment of GIST)
• DOC
• Dasatinib or IFN alpha
• Rx of accelerated or blast phase
• Hydroxyurea
• Arsenic can also be used
• Leukapheresis & splenectomyTONY SCARIA
2010 KMC
57. 22-04-2018
TONY SCARIA
2010 KMC
Polycythemia rubra
• the most common of the chronic myeloproliferative disorders
• characterized by the increased number of erythroid, granulocytic and
megakaryocytic cells (panmyelosis)
• Mutation in JAK 2 tyrosine kinase pathway
• Can be
• Polycythemia rubra vera (primary polycythemia)
• Secondary polycythemia
TONY SCARIA
2010 KMC
58. 22-04-2018
TONY SCARIA
2010 KMC
• Increased red cell mass
• Microcytosis with erythrocytosis
• Hb >18.5 in in males 16.5 in females
• Hyperviscosity stagnation of blood flow
• Thrombosis
• Deoxygenation cyanosis
TONY SCARIA
2010 KMC
59. 22-04-2018
• Extra medullary hematopoesis organomegaly
• Bone marrow trilineage hyperplasia
• High cell turn over hyperuricemia
• Platelet dysfunction bleeding & thrombotic events
• Basophilia histamine release aquagenic pruritus & peptic ulcer
TONY SCARIA
2010 KMC
• Erythropoietin is elevated in secondary polycythemia
• Decreased or normal in PCV
TONY SCARIA
2010 KMC
60. 22-04-2018
• Causes of secondary polycythemia
• Hypoxia
• High altitude
• Lung Ca
• Smoking
• COPD
• Congenital cyanotic heart ds
• Secondary tumours producing erythropoietin
• Renal cyst
• Hypernephroma
• Hydronephrosis
• Renal A stenosis
• Cerbellar haemangioblastoma
• Hepatoma
• Pheochromocytoma TONY SCARIA
2010 KMC
Features of polycythemia
• Increased levels of vitamin B12
• Microcytosis with erythrocytosis
• Increased LAP score
• Decreased ESR
• Decreased ESR
• Polycythemia
• Afibroginemia
• CHF
• Microcytosis with erythrocytosis
• c/c hypoxia
• PCV
• Beta thalassemia
TONY SCARIA
2010 KMC
61. 22-04-2018
• Rx
• venesection
• Anagrelide
• Decreases platelet production
• CTx
• Hydroxyurea
• Radioactive phosphorous
TONY SCARIA
2010 KMC
• Spurious / low plasma volume polycythemia
• Gaisbock syndrome
• Decrease in plasma volume relative increase in red cell count Hb haematocrit
TONY SCARIA
2010 KMC
63. 22-04-2018
Diagnostic criteria
• Sustained platelet count >4.5 lakhs/mm3
• BM biopsy
• Megakaryocyte proliferation with large & mature morphology
• Not meeting WHO critera for CML PV PMF MDS
• Demonstration of JAK2 mutation or other clonal marker
• No evidence of reactive thrombocytosis
TONY SCARIA
2010 KMC
TONY SCARIA
2010 KMC
68. 22-04-2018
Myeloproliferative /
myelodysplastic neoplasm
TONY SCARIA
2010 KMC
• Clonal myeloid disorders
• Both dysplastic & proliferative features not classified in MDS /MPN
• Chronic myelomonocytic leukemia (CMML)
• Juvenile myelomonocytic leukemia
• Atypical CML
TONY SCARIA
2010 KMC
69. 22-04-2018
CMML
• Most common MDS MPN
• Absence of Philadelphia chromosome
TONY SCARIA
2010 KMC
TONY SCARIA
2010 KMC
70. 22-04-2018
JMML
• children <2yrs
• 2% child hood leukemia
• Children with NF1 are at increased risk for development of JMML
TONY SCARIA
2010 KMC
Major criteria (all the three)
• Absence of Ph chromosome
• Peripheral monocytes greater
than 1*10^9 /L
• Less than 20 % blast
Minor criteria
• HbF raised
• Immature granulocytes in
peripheral blood
• WBC count > 1*10^9 /L
• Clonal chromosomal
abnormality (monosomy 7)
• GM CSF hypersensitivity of
myeloid progenitors in vitroTONY SCARIA
2010 KMC
73. 22-04-2018
TONY SCARIA
2010 KMC
Mantle cell lymphoma
• B cell lymphoma
• Arises from naive B cells
• Males of 50 – 60 yrs
• Presents as painless lymphadenopathy
TONY SCARIA
2010 KMC
74. 22-04-2018
T(11:14) is seen in mantle zone lymphoma
Bcl 1 = cyclin D!
TONY SCARIA
2010 KMC
• Express cyclin D1 (= Bcl1) &
surface Ig
• CD 5+ CD23-ve (CD5 +ve CD
23 +ve in CLL)
• Charcteristic pattern of
spread is also known as
LYMPHOMATOID POLYPOSIS
LYMPHOMATOID POLYPOSIS
TONY SCARIA
2010 KMC
75. 22-04-2018
Diffuse large b cell lymphoma
• Most common NHL
• Most malignant WORST prognosis
• Affects older individual Medial age of 60 years
• mature B cell tumour
TONY SCARIA
2010 KMC
Immunophenotyping of DLBL
• CD 19 CD20
• Variable expression of germinal center markers such as Bcl-6 or CD10
• Surface Ig+
TONY SCARIA
2010 KMC
76. 22-04-2018
Cytogenetics of DLBL
• Translocations involving Bcl-6
• Translocation t(14:18)
overexpression of Bcl-2 decreased
apoptosis
• MYC tranlocatins
TONY SCARIA
2010 KMC
Special types of DLBL
• Immunodeficiency associated large B cell lymphoma
• In severe T cell immunodeficiency like HIV & bone marrow transplantation
• Neoplastic cells are latently infected with EBV
• Restoration of T cell immunity regression of tumour
• Primary effusion lymphoma
• Seen in elderly
• As malignant pleural or ascetic effusion
• Tumour cells anaplastic lack T or B cell markers
• Tumour cells are infected with human Kaposi sarcoma herpes virus
TONY SCARIA
2010 KMC
77. 22-04-2018
Follicular lymphoma
• B cell lymphoma arising from germinal
centre
• LN biopsy
• Centrocytes
• Small cells with cleaved nuclear contours &
scanty cytoplasm (buttock cells )
• Centroblast
• Large cells with open nuclear chromatin
several nucleoli modest amount of cytoplasm
TONY SCARIA
2010 KMC
TONY SCARIA
2010 KMC
78. 22-04-2018
• BM biopsy paratrabecular
lymphoid aggregates in follicular
lymphoma
TONY SCARIA
2010 KMC
Translocation of 14 : 18 follicular
lymphoma
Over expression of Bcl2
30-50 % transform in to DLBCL
TONY SCARIA
2010 KMC
79. 22-04-2018
Cytogenetics of follicular lymphoma
• CD19 CD20
• Arising from germinal centre Bcl -6 & CD10
TONY SCARIA
2010 KMC
Marginal zone lymphoma MALToma
• Mucosa associated lymphoid issue MALToma
• Resembles normal marginal zone B cell
• Most common site is stomach
• 3 characteristic features
• a/w c/c inflammatory conditions
• like psojgrens syndrome
• Hashimotos thyroiditis
• Stomach H pylori infection
• Remain localized for long periods
• Regress on removal of inciting stimulus
• Upregulation of Bcl10 or MALT1
TONY SCARIA
2010 KMC
81. 22-04-2018
Burkitts lymphoma
• Peripheral B cell neoplasm
• ALL L3
• most common cause of tumour lysis syndrome
TONY SCARIA
2010 KMC
T(8:14)in burkitts lymphoma
TONY SCARIA
2010 KMC
83. 22-04-2018
3 categories of burkitts lymphoma
• African endemic
• Sporadic (non endemic)
• HIV associated aggressive
TONY SCARIA
2010 KMC
African endemic
• Most commonly affects face
/mandible
• Children / young adults
• All cases will be latently infected with
EBV
TONY SCARIA
2010 KMC
84. 22-04-2018
Sporadic (nonendemic ) BL
• Seen in children /young adults
• Presents as Illeocaecal / peritoneal
mass
• 15 – 20 % latently infected with EBV
TONY SCARIA
2010 KMC
HIV associated aggressive lymphomas
• 25 % of the patients are latently infected by EBV
TONY SCARIA
2010 KMC
85. 22-04-2018
Starry sky pattern due to apoptotic tumour
cell laden foamy macrophages
TONY SCARIA
2010 KMC
TONY SCARIA
2010 KMC
86. 22-04-2018
• Immunophenotyping reveals the cells expressing
• bcl-6 protein,
• surface Ig, CD19, CD20 and
• CD10 (CALLA)
TONY SCARIA
2010 KMC
TONY SCARIA
2010 KMC
88. 22-04-2018
Hairy cell leukemia
• Middle aged
• Male (M:F=6:1)
• Indolent course
• Peripheral B cell neoplasm
TONY SCARIA
2010 KMC
• Hairy cells are best seen by phase contrast microscopy
TONY SCARIA
2010 KMC
89. 22-04-2018
Triad of HCL
• Pancytopenia
• Massive splenomegaly (no lymph node enlargement)
• Most common presentation
• Vasculitis like syndrome (erythema nodosum)
TONY SCARIA
2010 KMC
TRAP positivity
TONY SCARIA
2010 KMC
91. 22-04-2018
Immunophenotyping
• Pan B markers
• CD 19 CD 20 surface Ig
• Monocyte specific
• CD11c
• CD25
• Characteristically expression of hairy cell leukemia
• CD103
• T cell specific
• Annexin A1
• Best & specific
TONY SCARIA
2010 KMC
TONY SCARIA
2010 KMC
92. 22-04-2018
• Rx
• Chemosensitive
• Cladiribine & deoxycoformycin
• Splenectomy for severe pancytopenia
• Good prognosis
TONY SCARIA
2010 KMC
Peripheral T cell neoplasm
TONY SCARIA
2010 KMC
93. 22-04-2018
Mycosis fungoides
• Tumour of CD4 + helper T cells
• Epidermotropism
• d/t cutaneous localizaition of tumour cells
• Chemokine receptors CCR4 & CCR10
TONY SCARIA
2010 KMC
Pautriers microabscess
TONY SCARIA
2010 KMC
95. 22-04-2018
TONY SCARIA
2010 KMC
Mycosis fungoides (cutaneous T cell
lymphoma)
• NHL presenting with skin infiltration
• MC primary cutaneous lymphoma of T cell origin
• In middle aged males and blacks
• C/F
• Pruritic localised erythematous plaques on trunk > 5 cm
TONY SCARIA 2010 KMC
96. 22-04-2018
Pautrier microabscess is characteristic of MF.
pleomorhic lymphocytes as clusters in epidermis
TONY SCARIA 2010 KMC
Sezary syndrome
• Advanced MF with lypmpadenpathy and visceral spread
• Generalised exfoliative erythroderma
• Circulating atypical lymphocytes(sezrry cells)
• Detected by T – cell rearrangement test
TONY SCARIA 2010 KMC
97. 22-04-2018
• Mycosis fungoides is an indolent cutaneous T-cell lymphoma (indolent
course) but is inevitably fatal (not easily amenable to treatment), except for
patients in stage I.
• Localised d/s
• Topical N2 mustard, corticosteroids,bexarotene PUVA
• Advanced
• PUVA+ oral retinoids
• Electron beam therapy
• denileukin
• Romidepsin
• Vorinostat
• Alemtuzumab(anti – CD 52 Ab)
• histone deacetylase inhibitors
TONY SCARIA 2010 KMC
• It has 3 phases
• Inflammatory premycotic phase
• Plaque phase
• Tumor phase
TONY SCARIA 2010 KMC
98. 22-04-2018
TONY SCARIA 2010 KMC
sezary syndrome
• Leukemic phase of
disease
• Sezry cells in peripheral
smear
• Cerebriform nuclei
• Generalized exfoliative
erythroderma
TONY SCARIA
2010 KMC
99. 22-04-2018
Large granular lymphocytic leukemia
• Occuring mainly in adults
• Neutropenia anemia
• Pure red cell aplasia anemia
• a/w
• Rheumatological disorder
• feltys syndrome
• RA
• Splenomegaly
• Neutropenia
TONY SCARIA
2010 KMC
Adult T cell leukemia
• Neoplasm of CD4 + T cells
• Endemicity
• CF
• Lymhadenopathy
• HSM
• Skin lesions
TONY SCARIA
2010 KMC
103. 22-04-2018
NK cells
TONY SCARIA
2010 KMC
NK cell granuloma
• Extranodal Midline
• Destructive nasopharyngeal mass
• Invade vessels ischemic necrosis
• EBV associated
• CD 16 & 56
• CD 3 –ve
TONY SCARIA
2010 KMC
104. 22-04-2018
Miscellaneous
TONY SCARIA
2010 KMC
Post transplantation lympho proliferative ds
• Diverse group of abnormal lymphoid growth
• Consisting of both hyperplasia & neoplasia
• Majority are Bcell origin
• Rarely t cell or NK cell
TONY SCARIA
2010 KMC
106. 22-04-2018
TONY SCARIA
2010 KMC
• Arises single node and spreads by contiguous spread
• Reed sternberg cells
• derived from the germinal center B cell
• induces the accumulation of reactive lymphocytes, macrophages and
granulocytes
• Neoplastic giant cell
• Owl eye appearance
• Also seen in IMN
• NHL (immunoblastic NHL)
• Carcinoma & sarcoma
TONY SCARIA
2010 KMC
108. 22-04-2018
• “owl-eye” appearance
• due to the presence of symmetric
(mirror image) bilobed nucleus
with prominent nucleoli
surrounded by clear space
• PAX 5 is best marker for reed
Sternberg cell
TONY SCARIA
2010 KMC
TONY SCARIA
2010 KMC
109. 22-04-2018
• Classical reed Sternberg cells
• Express PAX5 CD15 & CD30
• Lymphohistiocytic variant
• Will express germinal center B cells (CD20 & Bcl 6)
TONY SCARIA
2010 KMC
TONY SCARIA
2010 KMC
111. 22-04-2018
NODULAR SCLEROSIS TYPE
• MOST COMMON IN WORLD
• abundant collagen +
• Mediatinal involvement common
TONY SCARIA
2010 KMC
TONY SCARIA
2010 KMC
112. 22-04-2018
Mixed cellularity
• Most common in developing countries
• Biphasic incidence
Young age >55 years
TONY SCARIA
2010 KMC
TONY SCARIA
2010 KMC
114. 22-04-2018
Lymphocyte predominant
• Popcorn cell
• L&H variant
• fluffy, lobulated nucleus having fine chromatin and small nucleoli.
TONY SCARIA
2010 KMC
TONY SCARIA
2010 KMC
115. 22-04-2018
TONY SCARIA
2010 KMC
CF of hodgkins lymphoma
• Alcohol increases symptoms
• Pel ebstein fever
• Fever which cyclically increase in one
or two weeks
• Painless rubbery enlargement of LN
• Paraneoplastic syndrome in HL
• Secondary amyloidosis (AA)
• Alchol induced pain in LN
TONY SCARIA
2010 KMC
116. 22-04-2018
Adverse prognostic factors
• Age > 45 yrs
• Male
• Hb <10.5gm/dL
• Leucocyte count >15000
• Lymphocytopenia
• Absolute lymphocyte count <600/ul
• Lymphocyte <8 %
• Serum albumin <4gm/dL
• Stage IV TONY SCARIA
2010 KMC
TONY SCARIA
2010 KMC
117. 22-04-2018
Best prognosis
• Lymphocyte predominant >> nodular sclerosis
TONY SCARIA
2010 KMC
Bad prognosis
• Mediastinal involvement
• Lymphocyte depletion type
• Systemic symptoms
TONY SCARIA
2010 KMC
121. 22-04-2018
Multiple myeloma
• Clonal plasma cells >10 % on BM biopsy
• Or in any quantity in biopsy from other tissues plamcocytoma
• Monoclonal protein in either serum or urine
• Except in cases of true non secretory myeloma
• Evidence of end organ damage
• CRAB
• Calcium elevation >11.5 Hypercalcemia
• Renal insufficiency (s creatinine >2mg/dl
• Anemia (haemoglobin <10gm/dl)
• Bone lesions (lytic lesion/osteoporosis with compression#)
TONY SCARIA
2010 KMC
Plasma cell leukemia
TONY SCARIA
2010 KMC
123. 22-04-2018
Radiographically
• Punched out lesions will be
seen
• Vertebrae is most commonly
involved
• Vertebra>>ribs>>skull>.pelvis
>>femur >> clavicle
TONY SCARIA
2010 KMC
Hypercalcemia
• Hypercalcemia metasatic calcification
TONY SCARIA
2010 KMC
127. 22-04-2018
• Definitive diagnosis is with bone marrow examination
TONY SCARIA
2010 KMC
Marked rouleaux formation d/t M proteins
TONY SCARIA
2010 KMC
133. 22-04-2018
Poor prognostic factors for multiple myeloma
• Serum β2 macroglobulin >6mg/dl
• Best prognostic marker
• CRP > 6mg/dl
• Presence of plasmablastic morphology
• Bone marrow biopsy diffuse pattern & prominent angiogenesis
• Serum LDH raised
• Serum creatinine > 2mg/dl
• Plasma cell labelling index > 3 %
• Cytogenetics
• Deletion of 13q 11p
• Monosomy 13
• Hypodiploidy TONY SCARIA
2010 KMC
In multiple myeloma
• Anion gap is less than normal
• Bcz M protein is cationic leads to retention of chloride
TONY SCARIA
2010 KMC
134. 22-04-2018
Rx
• Thalidomide
• Leflunomide
• Bortezomib proteasome inhibitor
TONY SCARIA
2010 KMC
• Plasma cell leukemia
• Plasma cells more than 20 % of cells
• Absolute plasma cell count of more than 2000cells /mm3
TONY SCARIA
2010 KMC
135. 22-04-2018
• Nonsecretory myeloma
• No M band in serum or urine
• All other symptoms of MM+
• Rare
TONY SCARIA
2010 KMC
Waldenstroms macroglobulinemia
• B cell neoplasm
• Affecting 60 -70 yrs
• No bone destructin
TONY SCARIA
2010 KMC
137. 22-04-2018
MGUS
• presence of M spike without associated disease of the B cells. MGUS is the
• commonest cause of monoclonal gammopathy. Around 1% of the patients
with MGUS progress to develop multiple myeloma per year. It is usually a
diagnosis of exclusion.
• Patients of MGUS have less than 3 g/dL of monoclonal protein in the serum
and no Bence Jones proteinuria
• Normal calcium
• Rx
• Symptomatic
• Follow up TONY SCARIA
2010 KMC
Heavy chain disease
TONY SCARIA
2010 KMC
139. 22-04-2018
• Cleaved nucleus
• Several granules in cytoplasm
BIRBECK granules
TONY SCARIA
2010 KMC
TONY SCARIA
2010 KMC
140. 22-04-2018
Clinicopathological entities of LCH
• Letterer – siwe disease
• Multifocal multisystem
• Aggressive systemic disorder occurring before 2 yrs of age
• Presents like seborrheic dermatitis
• Bone destruction involving all bones of body
• Eosinophilic granuloma
• Unifocal & multifocal unisystem
• Mc presentation is calvarial skull defect
• Hand schuller Christian syndrome
• Calvarial bone defects
• Diabetes insipidus
• Exophthalmos
• Pulmonary lan
TONY SCARIA
2010 KMC
TONY SCARIA
2010 KMC
144. 22-04-2018
Forward scatter
• To determine cell size
TONY SCARIA
2010 KMC
Side scatter
• For density of cell (granularity
vacuoles membrane size )
• Granulocytes & monocytes have
more granularity hence more
scattering
TONY SCARIA
2010 KMC
145. 22-04-2018
• Pan-B cell markers are CD19, 20 and 21. CD21 is also acts as the
receptor of EBV.
TONY SCARIA
2010 KMC
Clinical uses of flow cytometry
• Diagnosis of PNH
• Reticulocyte enumeration
• Leukemia & lymphoma phenotyping
• transplant rejection
• Lymphocytosis
TONY SCARIA
2010 KMC
151. 22-04-2018
Alder reily anomaly
• In mucopolysacharidose
• AR inherited MPS
• Mucopysaccharidoses
TONY SCARIA
2010 KMC
TONY SCARIA
2010 KMC
152. 22-04-2018
May hegglin anomaly
• AD
• Associated with macrothrombocytes
• Giant platelets with thrombocytopenia
TONY SCARIA
2010 KMC
TONY SCARIA
2010 KMC
154. 22-04-2018
Kimuras disease
• Eosinophilic lymphadenitis
TONY SCARIA
2010 KMC
• The LAP score is usually decreased in chronic myelogenous leukemia
and paroxysmal nocturnal hemoglobinuria, while it is increased in
leukemoid reaction and polycythemia vera.
TONY SCARIA
2010 KMC